All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the MPN Advocates Network.
The MPN Hub is pleased to present a visual abstract highlighting key updates and changes in the 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.
Updates are focused on the changes in the rationale behind the classification of myeloproliferative neoplasms and mastocytosis, focusing on combined morphologic, immunophenotypic, molecular, and cytogenetic data that help to refine diagnostic criteria and emphasize therapeutically and/or prognostically actionable biomarkers.
To download this visual abstract, click below.Download here
Prevalence of pulmonary hypertension in patients with MPN and the associated risk factors
Pulmonary hypertension (PH) is a serious condition that can present with right ventricular dysfunction, fatigue, dyspnea, syncope, chest pain, palpitations, and...
Genome-wide sequencing enables genetic distinction of MDS/MPN subtypes
Based on the World Health Organization (WHO), myelodysplastic/myeloproliferative neoplasms (MDS/MPN) are a group of myeloid neoplasms with clinical and pathological...
Subscribe to get the best content related to MPN delivered to your inbox